Log in to search using one of your social media accounts:

 

Evidence Scant for Treatment of Cough With the Common Cold

Update recommends against nonsteroidal anti - inflammatory agents for adults, codeine for children
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Allergy, Emergency Medicine, Nursing, ENT, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Related Links:

Every child gets a cough from time to time; there’s really no escaping them. It’s completely normal for children to catch several colds a year, especially if they are in daycare or go to school, and common allergies can cause a cough too. Most of the time, it’s nothing to worry about. Most of the time, some rest, plenty of fluids, honey (for children over a year old) and some patience and TLC do the trick. But sometimes, it’s important to call the doctor. Here’s when you should worry about a cough: 1. Your child is having trouble breathing. Signs of this include: Breathing quickly “Suc...
Source: Thrive, Children's Hospital Boston - Category: Pediatrics Authors: Tags: Health & Wellness Claire McCarthy MD cough Source Type: news
If you or your child has ever had acute conjunctivitis or “pink eye,” you know how nasty it can be.  “Crusty,” “goopy,” “bloodshot,” “itchy,” and “gritty” are all common words used to describe the eye condition that affects some six million people in the US every year. What is conjunctivitis exactly? Conjunctivitis is inflammation of the conjunctiva, which is the thin membrane that covers the whites of the eyes. There are three main types of conjunctivitis: allergic, viral, and bacterial. Allergic conjunctivitis often accompanies other allergy sy...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Cold and Flu Drugs and Supplements Eye Health Infectious diseases Source Type: blogs
Conclusions:The results of the 5 year interim analysis of PANGAEA support the positive benefit-risk profile fingolimod demonstrated in phase III clinical trials with real world evidence data. The frequency/nature of reported adverse events is consistent with previous findings from clinical trials.Study Supported by: This study was supported by the Novartis Pharma GmbH, Nuremberg, Germany.Disclosure: Dr. Ziemssen has received personal compensation for activities with Dr. Albrecht has received personal compensation for activities with Sanofi Genzyme, Novartis, and Biogen. Dr. Haas has received personal compensation for activ...
Source: Neurology - Category: Neurology Authors: Tags: Disease Modifying Therapy for Multiple Sclerosis: Efficacy and Clinical Trial Outcomes II Source Type: research
After a fairly slow 2016, the United States Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) issued a quick burst of letters in the span of nine days in December. This flurry of activity more than doubled the enforcement letters that had been issued up to that point in the year. Although there was an apparent increase in enforcement activity in December (perhaps related to the new Administration and the mark the old Administration wanted to leave on the industry), the type of activity and the nature of Draft Guidances issued in 2017 prior to the Trump Administration taking office ind...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs
Authors: Song JW, Jang YS, Jung MC, Kim JH, Choi JH, Park S, Hwang YI, Jang SH, Jung KS Abstract Levodropropizine is commonly used as an antitussive drug for acute and chronic cough. It is a non-opioid agent with peripheral antitussive action via the modulation of sensory neuropeptide levels in the airways. Thus, levodropropizine has a more tolerable profile than opioid antitussives. However, we experienced 3 cases of levodropropizine-induced anaphylaxis. Three patients commonly presented with generalized urticaria, dyspnea, and collapse after taking cold medication including levodropropizine. To find out the culpr...
Source: Allergy, Asthma and Immunology Research - Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research
Abstract The system that protects body from infectious agents is immune system. On occasions, the system seldom reacts with some foreign particles and causes allergy. Allergies of the ear, nose and throat (ENT) often have serious consequences, including impairment and emotional strain that lowers the quality of life of patients. This is further responsible for the common cold, cough, tonsillitis, dermal infection, chest pain and asthma-like conditions which disturb one's day to day life. The present review enlightens some common ENT allergies which one can suffer more frequently in one's lifetime, and ignorance le...
Source: Allergologia et Immunopathologia - Category: Allergy & Immunology Authors: Tags: Allergol Immunopathol (Madr) Source Type: research
CONCLUSIONS: Our findings suggest that multimorbidities among childhood asthma, allergies, and respiratory illnesses are likely not random, but rather share etiology. Specific patterns of childhood asthma multimorbidities perhaps differ between boys and girls and between children with and without FHA. PMID: 27880051 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
It was February, and clinic was teeming with respiratory infections of all kinds: mostly the common cold, but also bronchitis, pneumonia, and sinus infections. The first patient on my schedule was a healthcare provider with “sinus infection” written down as her main issue.* She’d had about two weeks of nasal and sinus congestion which she blamed on a viral upper respiratory infection (URI, also known as the common cold). Her two young kids had been sick with colds all winter, so she wasn’t surprised to have these symptoms, along with endless postnasal drip and a cough. Her congestion had improved a ...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Asthma and Allergies Cold and Flu Drugs and Supplements Infectious diseases sinus infection Source Type: blogs
Conclusions: The results of the 4 year interim analysis of PANGAEA support the positive benefit-risk profile fingolimod demonstrated in phase III clinical trials with real world evidence data. The number of reported adverse events is consistent with previous findings from clinical trials.Disclosure: Dr. Ziemssen has received personal compensation for activities with Bayer Schering Pharma, Biogen Idec, EMD Merck Serono, Genentech, Genzyme, Novartis, Sanofi-Aventis, Teva Pharmaceutical, and Almirall. Dr. Albrecht has received personal compensation for activities with Genzyme -Sanofi, Novartis, and Biogen. Dr. Haas has receiv...
Source: Neurology - Category: Neurology Authors: Tags: MS and CNS Inflammatory Disease: Treatment, Safety, and Tolerance Source Type: research
BOSTON (CBS) — Signs of spring are in the air but that’s not something you have to tell allergy sufferers. This season has arrived a bit earlier than usual. WBZ-TV’s Dr. Mallika Marshall has been seeing patients in her clinic for the past couple of weeks who are already complaining about their allergies. Much of that is due to warmer temperatures. In fact, some areas are seeing tree pollen a month earlier than usual. Grass and flower pollen will soon follow. Since it is still cold and flu season, how can you tell what is bothering you? Dr. Marshall says there is some overlap in symptoms like nasal congest...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Allergies Cold Dr. Mallika Marshall Source Type: news
More News: Allergy | Allergy & Immunology | Children | Common Cold | Cough | Emergency Medicine | Geriatrics | Internal Medicine | Nurses | Nursing | Pediatrics | PET Scan | Respiratory Medicine